Zim Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹105.27 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.12 per cent from ₹108.66 crore. This corresponds to a year-on-year *(YoY) decline of 3.18 per cent.
Operating Profit
Operating Profit stands at ₹7.19 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 43.87 per cent from ₹12.81 crore. This corresponds to a year-on-year *(YoY) decline of 50.72 per cent.
PBDT
PBDT stands at ₹10.04 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 9.39 per cent from ₹11.08 crore. This corresponds to a year-on-year *(YoY) decline of 25.02 per cent.
Profit Before Tax
Profit Before Tax stands at ₹4.94 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.35 per cent from ₹6.05 crore. This corresponds to a year-on-year *(YoY) decline of 39.01 per cent.
Net Profit
Net Profit stands at ₹3.74 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 15.00 per cent from ₹4.40 crore. This represents a 23.36 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Zim Laboratories Ltd Earnings
- YOY
- QOQ
Zim Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Zim Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Zim Laboratories Ltd Financial Reports
Zim Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Zim Laboratories | -0.04% | -0.79% | 15.83% | 42.03% | 40.39% | 9.65% |
| Sigachi Indust. | 1.57% | 2.22% | -1.38% | 2.68% | -40.31% | -52.41% |
| Anuh Pharma | -0.43% | -5.23% | -8.53% | -2.66% | -1.26% | -25.98% |
| Kilitch Drugs | 4.35% | 9.65% | 23.77% | 16.99% | 7.93% | -16.63% |
| Jenburkt Pharma | 0.90% | 0.41% | 10.40% | 17.14% | -2.35% | -1.34% |
| Haleos Labs Limited | 2.69% | 0.00% | 24.93% | 28.90% | 23.93% | 26.47% |
| Amanta Healthcar | 0.74% | -2.48% | -2.88% | 23.81% | 15.71% | -7.57% |
Company Info
Company Information
Chairman & Managing Director : Anwar S Daud
Director (Finance) : Zulfiquar M Kamal
Whole Time Director : Prakash Sapkal
Director (Business Development) : Niraj Dhadiwal
Independent Director : Kavita Loya
Independent Director : Padmakar Joshi
Company Sec. & Compli. Officer : Piyush Nikhadi
Independent Director : Kamlesh Shende
Independent Director : Ashok Bhatia